Background: Despite extensive research on the epidemiological risk factors linking diabetes and carotid plaques, evidence regarding sex-specific differences remains scarce. This study aims to investigate the gender differences in the association between fasting blood glucose levels and the risk of carotid plaques among cardiovascular high-risk populations.
Methods: This study used cross-sectional data from a large prospective cohort study. From 2019 to 2020, fasting blood glucose and carotid ultrasound examinations were conducted on high-risk cardiovascular populations in the pilot area. The independent variable was fasting blood glucose, and the dependent variable was the presence or absence of carotid plaques. A multivariable logistic regression model was used to calculate risk ratios. Generalized additive models combined with curve fitting were employed to assess the nonlinear relationship between fasting blood glucose levels and carotid plaques in the overall population and different genders.
Results: This study included 1,063 cardiovascular high-risk patients. In the fully adjusted model, fasting blood glucose levels in men were positively associated with carotid plaques (OR = 1.21, 95% CI: 1.02-1.45, p = 0.0312). In women, fasting blood glucose levels were also positively associated with the risk of carotid plaque formation (OR = 1.15, 95% CI: 0.95-1.39). The generalized additive model results showed a linear relationship between fasting blood glucose levels and carotid plaques in the overall population. Stratified results indicated a linear relationship in men, while a nonlinear relationship was observed in women.
Conclusion: There is an association between fasting blood glucose levels and carotid plaque, with an increased risk of carotid plaque as fasting blood glucose rises. Moreover, this relationship differs between sexes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11880609 | PMC |
http://dx.doi.org/10.3389/fendo.2025.1478640 | DOI Listing |
Front Endocrinol (Lausanne)
March 2025
Department of Endocrinology & Metabolism, Shenzhen University General Hospital, Shenzhen, China.
Background: The gut microbiota plays a pivotal role in various metabolic disorders. Orlistat has shown beneficial effects on weight loss and metabolism, but its direct impact on the gut microbiota has not been extensively reported. Thus, this study aimed to explore the effects of orlistat on the gut microbiota in mice with high-fat diet-induced obesity.
View Article and Find Full Text PDFFront Med (Lausanne)
February 2025
Department of Hematology and Oncology, Faculty of Medicine, Augsburg University Hospital, University of Augsburg, Augsburg, Germany.
The treatment landscape for chronic lymphocytic leukemia (CLL) has expanded dramatically over the last decade, with a wide range of effective treatments now available. Clinical management of CLL varies widely depending on patient profile, meaning the optimal treatment in Arab patients, who tend to be young and often present with comorbidities, including diabetes and obesity, requires specific considerations. In the absence of regional guidelines, a group of experts from across the Gulf region and one international expert from Germany convened to discuss and agree upon a position statement for venetoclax-based fixed-duration treatment strategies for Arab patients with CLL.
View Article and Find Full Text PDFNutrients
March 2025
Higher Institute of Biomedical Sciences, State University of Ceara-UECE, Fortaleza 60714-903, CE, Brazil.
Background/objectives: Yacon syrup () has gained attention due to its high concentration of fructooligosaccharides (FOSs) and associated health benefits. This systematic review aimed to evaluate the effects of yacon syrup on metabolic parameters and intestinal health in humans over the last decade.
Methods: Following PRISMA guidelines, we conducted a systematic search in databases, including Medline (PubMed), Science Direct, Embase, Scopus, and SciELO, up to October 2024.
Nutrients
February 2025
Department of Engineering for Innovation Medicine, University of Verona, 37100 Verona, Italy.
: Metabolic syndrome (MS) is a cluster of cardiovascular and metabolic risk factors that increase the likelihood of both acute events and chronic conditions. While exercise has been shown to improve individual risk factors associated with MS; research on its effects on MS as an integrated condition remains limited. This study aims to evaluate the effectiveness of a 6-month Adapted Personalized Motor Activity (AMPA) program for improving the health outcomes of individuals with MS.
View Article and Find Full Text PDFNutrients
February 2025
Department of Midwifery and Women's Health, Division of Health Sciences and Nursing, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
: Glucose and lipid metabolism during pregnancy are crucial for perinatal outcomes. Recently, chrono-nutritional factors have been partially identified as influencing pregnancy metabolism. This study aimed to investigate overnight fasting duration and meal frequency during pregnancy and to clarify their associations with glucose and lipid metabolism.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!